These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 10509870
1. The linoleic acid metabolite, 13-HpODE augments the phosphorylation of EGF receptor and SHP-2 leading to their increased association. Hui R, Kameda H, Risinger JI, Angerman-Stewart J, Han B, Barrett JC, Eling TE, Glasgow WC. Prostaglandins Leukot Essent Fatty Acids; 1999 Aug; 61(2):137-43. PubMed ID: 10509870 [Abstract] [Full Text] [Related]
2. The linoleic acid metabolite, (13S)-hydroperoxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of receptor dephosphorylation. Differential response in Syrian hamster embryo tumor suppressor phenotypes. Glasgow WC, Hui R, Everhart AL, Jayawickreme SP, Angerman-Stewart J, Han BB, Eling TE. J Biol Chem; 1997 Aug 01; 272(31):19269-76. PubMed ID: 9235921 [Abstract] [Full Text] [Related]
3. 13(S)-HpODE modulates mitogenic signal transduction through enhancing the phosphorylation and association of EGF receptor with the tyrosine phosphatase SHP-2. Glasgow WC, Hui R, Kameda H, Eling TE. Adv Exp Med Biol; 2002 Aug 01; 507():463-7. PubMed ID: 12664627 [No Abstract] [Full Text] [Related]
4. Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling. Keilhack H, Tenev T, Nyakatura E, Godovac-Zimmermann J, Nielsen L, Seedorf K, Böhmer FD. J Biol Chem; 1998 Sep 18; 273(38):24839-46. PubMed ID: 9733788 [Abstract] [Full Text] [Related]
5. A common requirement for the catalytic activity and both SH2 domains of SHP-2 in mitogen-activated protein (MAP) kinase activation by the ErbB family of receptors. A specific role for SHP-2 in map, but not c-Jun amino-terminal kinase activation. Deb TB, Wong L, Salomon DS, Zhou G, Dixon JE, Gutkind JS, Thompson SA, Johnson GR. J Biol Chem; 1998 Jul 03; 273(27):16643-6. PubMed ID: 9642214 [Abstract] [Full Text] [Related]
10. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584. Vogel W, Ullrich A. Cell Growth Differ; 1996 Dec 03; 7(12):1589-97. PubMed ID: 8959326 [Abstract] [Full Text] [Related]
11. Transient association of the phosphotyrosine phosphatase SHP-2 with TrkA is induced by nerve growth factor. Goldsmith BA, Koizumi S. J Neurochem; 1997 Sep 03; 69(3):1014-9. PubMed ID: 9282923 [Abstract] [Full Text] [Related]
12. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B. Wang LL, Blasioli J, Plas DR, Thomas ML, Yokoyama WM. J Immunol; 1999 Feb 01; 162(3):1318-23. PubMed ID: 9973385 [Abstract] [Full Text] [Related]
17. Epidermal growth factor stimulates the tyrosine phosphorylation of SHPS-1 and association of SHPS-1 with SHP-2, a SH2 domain-containing protein tyrosine phosphatase. Ochi F, Matozaki T, Noguchi T, Fujioka Y, Yamao T, Takada T, Tsuda M, Takeda H, Fukunaga K, Okabayashi Y, Kasuga M. Biochem Biophys Res Commun; 1997 Oct 20; 239(2):483-7. PubMed ID: 9344856 [Abstract] [Full Text] [Related]